Nephrocystin interacts with Pyk2, p130Cas, and tensin and triggers phosphorylation of Pyk2

被引:93
|
作者
Benzing, T
Gerke, P
Höpker, K
Hildebrandt, F
Kim, E
Walz, G [1 ]
机构
[1] Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany
[2] Univ Freiburg, Childrens Hosp, D-79106 Freiburg, Germany
关键词
D O I
10.1073/pnas.171269898
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Juvenile nephronophthisis type 1 is caused by mutations of NPHP1, the gene encoding for nephrocystin. The function of nephrocystin is presently unknown, but the presence of a Src homology 3 domain and its recently described interaction with p130(Cas) suggest that nephrocystin is part of the focal adhesion signaling complex. We generated a nephrocystin-specific antiserum and analyzed the interaction of native nephrocystin with endogenous proteins. Immunoprecipitation of nephrocystin revealed that nephrocystin forms protein complexes with p130(Cas), proline-rich tyrosine kinase 2 (Pyk2), and tensin, indicating that these proteins participate in a common signaling pathway. Expression of nephrocystin resulted in phosphorylation of Pyk2 on tyrosine 402 as well as activation of downstream mitogen-activated protein kinases, such as ERK1 and ERK2. Our findings suggest that nephrocystin helps to recruit Pyk2 to cell matrix adhesions, thereby initiating phosphorylation of Pyk2 and Pyk2-dependent signaling. A lack of functional nephrocystin may compromise Pyk2 signaling in a subset of renal epithelial cells.
引用
收藏
页码:9784 / 9789
页数:6
相关论文
共 50 条
  • [41] Tyrosine phosphorylation of Pyk2 is selectively regulated by Fyn during TCR signaling
    Qian, DP
    Lev, S
    vanOers, NSC
    Dikic, I
    Schlessinger, J
    Weiss, A
    JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (07): : 1253 - 1259
  • [42] Angiotensin II induces human monocyte migration and PYK2/paxillin phosphorylation
    Kintscher, U
    Wakino, S
    Kim, S
    Fleck, E
    Hsueh, WA
    Law, RE
    HYPERTENSION, 2000, 36 (04) : 680 - 680
  • [43] PYK2 as a Novel Therapeutic Target for Pancreatic Cancer
    Hu, J.
    PANCREAS, 2017, 46 (10) : 1407 - 1407
  • [44] Pyk2 promotes tumor progression in multiple myeloma
    Zhang, Yu
    Moschetta, Michele
    Daisy Huynh
    Tai, Yu-Tzu
    Zhang, Yong
    Zhang, Wenjing
    Mishima, Yuji
    Ring, Jennifer E.
    Tam, Winnie F.
    Xu, Qunli
    Maiso, Patricia
    Reagan, Michaela
    Sahin, Ilyas
    Sacco, Antonio
    Manier, Salomon
    Aljawai, Yosra
    Glavey, Siobhan
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    Pachter, Jonathan
    Roccaro, Aldo M.
    Ghobrial, Irene M.
    BLOOD, 2014, 124 (17) : 2675 - 2686
  • [45] Role of PYK2 in the development of obesity and insulin resistance
    Yu, Y
    Ross, SA
    Halseth, AE
    Hollenbach, PW
    Hill, RJ
    Gulve, EA
    Bond, BR
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 334 (04) : 1085 - 1091
  • [46] PYK2 at the Intersection of Signaling Pathways in Pancreatic Cancer
    Means, Anna L.
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2019, 8 (04): : 651 - 652
  • [47] Regulation of endothelial cell function by Fak and Pyk2
    Orr, AW
    Murphy-Ullrich, JE
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 1254 - 1266
  • [48] Pyk2/MCU Pathway and Treatment of Ischemic Stroke
    Zhang, K.
    Yan, J.
    Wang, L.
    Tian, X.
    Zhang, T.
    Guo, L.
    Li, B.
    Wang, W.
    Liu, X.
    CELL TRANSPLANTATION, 2016, 25 (04) : 778 - 779
  • [49] FAK家族的新成员——Pyk2
    林辉
    国外医学(生理、病理科学与临床分册), 2002, (02) : 153 - 155
  • [50] Convergent Effects of Resveratrol and PYK2 on Prostate Cells
    Conte, Andrea
    Kisslinger, Annamaria
    Procaccini, Claudio
    Paladino, Simona
    Oliviero, Olimpia
    de Amicis, Francesca
    Faicchia, Deriggio
    Fasano, Dominga
    Caputo, Marilena
    Matarese, Giuseppe
    Pierantoni, Giovanna Maria
    Tramontano, Donatella
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (09):